Athersys Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (52)

Latest Posts

About This Stock More About This Stock
Market Briefing For Monday, Dec. 21
Article By: Gene Inger
Monday, December 21, 2020 2:00 AM EDT
History is replete with those who tried to make the market go their way at a time when more powerful forces argued otherwise.
In this article: SRNE, TSLA, SPX Also: NVS, PFE, ATHX, HTBX, MESO, CVAC
Read
Market Briefing For Tuesday, July 21
Article By: Gene Inger
Tuesday, July 21, 2020 2:20 AM EDT
Tuesday may be a bit skittish but we see this market moving higher even as the case counts do as well; and it's not incongruous as to how this battle rages both for humanity and the weapons to fight this horrendous plague.
In this article: AMD, AZN, IBM, SRNE, ATHX, HTBX
Read
Market Briefing For Tuesday, April 28
Article By: Gene Inger
Tuesday, April 28, 2020 2:47 AM EDT
We do know that every sector of S&P has firmed, and it (backed by the Fed) continues grinding higher within the target range we've had now for well over a month. That's a zone I've referred to as between the 50-DMA and 200-DMA.
In this article: ATHX, PSTI, OIL, SPY, VIX, NYA, MESO, AYTU
Read
Stock Charts To Watch - Wednesday, April 1
Video By: Harry Boxer
Wednesday, April 1, 2020 9:09 PM EDT
Allied Healthcare Products, Inc. is still at the apex, but, still, on Wednesday it popped 2.56, or 15%, to 20.07, having reached a session high of 20.95, on 1 million shares traded and another 1.53, or 7.6%, to 21.60 in after-hours.
In this video: NCR, AHPI, ATHX, IFRX, TDOC, PTON
Watch
On The Fly: After Hours Movers
Article By: The Fly
Friday, March 11, 2016 3:57 AM EDT
Summary of some ups and downs of stocks after market close yesterday. Strata Skin Sciences is up 30% after reporting quarterly results and announcing that the FDA approved a PMA supplement for the MelaFind system
In this article: FXCM Also: FNSR, KTOS, ULTA, ATHX, BDSI, LOCO, BOJA, RUN, SSKN
Read

Latest Tweets for $ATHX

No tweets yet!

PARTNER HEADLINES